Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
130.00    -0.40 (-0.31%)
Bid:
129.60
Ask:
129.80
Spread: 0.20 (0.154%)
Market Cap: £316.44m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

7 Dec 2023 07:00

RNS Number : 9523V
PureTech Health PLC
07 December 2023
 

07 December 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

06 December 2023

Number of ordinary shares purchased:

50,961

Highest price paid per share:

153.60p

Lowest price paid per share:

145.00p

Volume weighted average price paid per share:

150.82p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,935,866 ordinary shares in treasury and has 272,532,293 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,532,293 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

06/12/2023

09:21:28

1026

150.2

XLON

00381204220TRLO0.1.1

06/12/2023

09:21:28

80

150.6

CHIX

00381204221TRLO0.1.1

06/12/2023

09:51:52

433

151.4

CHIX

00381210249TRLO0.1.1

06/12/2023

09:51:59

256

151.4

XLON

00381210274TRLO0.1.1

06/12/2023

09:52:23

10

151.4

XLON

00381210359TRLO0.1.1

06/12/2023

09:52:58

3

151.4

XLON

00381210453TRLO0.1.1

06/12/2023

10:12:04

357

151.8

XLON

00381214211TRLO0.1.1

06/12/2023

10:12:20

168

151.8

XLON

00381214279TRLO0.1.1

06/12/2023

10:12:57

279

151.8

XLON

00381214439TRLO0.1.1

06/12/2023

12:12:35

61

150.8

XLON

00381235203TRLO0.1.1

06/12/2023

12:12:35

54

150.8

XLON

00381235204TRLO0.1.1

06/12/2023

12:12:35

54

150.8

XLON

00381235205TRLO0.1.1

06/12/2023

12:13:08

4025

152

XLON

00381235279TRLO0.1.1

06/12/2023

12:13:08

539

152

XLON

00381235280TRLO0.1.1

06/12/2023

12:14:05

2402

152

XLON

00381235438TRLO0.1.1

06/12/2023

12:31:11

513

152.4

XLON

00381238320TRLO0.1.1

06/12/2023

13:20:32

1218

153.6

XLON

00381248130TRLO0.1.1

06/12/2023

13:20:32

321

153.6

XLON

00381248132TRLO0.1.1

06/12/2023

13:38:51

513

153.2

CHIX

00381252680TRLO0.1.1

06/12/2023

13:38:51

61

153.2

TRQX

00381252681TRLO0.1.1

06/12/2023

13:38:51

513

153.2

CHIX

00381252682TRLO0.1.1

06/12/2023

13:38:51

46

153.2

TRQX

00381252683TRLO0.1.1

06/12/2023

13:38:51

107

153.2

TRQX

00381252684TRLO0.1.1

06/12/2023

13:38:51

1026

153.2

XLON

00381252685TRLO0.1.1

06/12/2023

13:38:51

94

152.8

BATE

00381252686TRLO0.1.1

06/12/2023

13:38:51

88

152.8

BATE

00381252688TRLO0.1.1

06/12/2023

13:38:51

4

152.8

BATE

00381252687TRLO0.1.1

06/12/2023

13:38:52

3

152.8

BATE

00381252689TRLO0.1.1

06/12/2023

13:41:37

149

153

AQXE

00381253586TRLO0.1.1

06/12/2023

13:41:37

149

153

AQXE

00381253587TRLO0.1.1

06/12/2023

13:43:29

191

152.8

BATE

00381254158TRLO0.1.1

06/12/2023

13:43:29

8

152.8

BATE

00381254159TRLO0.1.1

06/12/2023

13:43:29

388

152.8

BATE

00381254160TRLO0.1.1

06/12/2023

13:43:29

513

152.8

CHIX

00381254161TRLO0.1.1

06/12/2023

14:17:24

107

152.8

TRQX

00381267291TRLO0.1.1

06/12/2023

14:17:24

2052

152.8

XLON

00381267292TRLO0.1.1

06/12/2023

14:17:24

108

152.6

CHIX

00381267293TRLO0.1.1

06/12/2023

14:17:24

114

152.6

CHIX

00381267294TRLO0.1.1

06/12/2023

14:17:24

291

152.6

CHIX

00381267295TRLO0.1.1

06/12/2023

14:17:24

54

152.6

CHIX

00381267296TRLO0.1.1

06/12/2023

14:22:47

299

152.6

CHIX

00381269103TRLO0.1.1

06/12/2023

14:27:09

58

152.6

CHIX

00381270553TRLO0.1.1

06/12/2023

14:30:08

102

152.6

CHIX

00381273185TRLO0.1.1

06/12/2023

14:30:08

482

152.6

CHIX

00381273186TRLO0.1.1

06/12/2023

14:30:08

442

152.6

CHIX

00381273187TRLO0.1.1

06/12/2023

14:30:08

301

152.4

XLON

00381273189TRLO0.1.1

06/12/2023

14:30:08

388

152.4

BATE

00381273188TRLO0.1.1

06/12/2023

14:30:08

488

152.4

XLON

00381273190TRLO0.1.1

06/12/2023

14:30:08

750

152.4

XLON

00381273191TRLO0.1.1

06/12/2023

14:30:23

400

152.8

AQXE

00381273445TRLO0.1.1

06/12/2023

14:31:15

149

151.8

AQXE

00381274376TRLO0.1.1

06/12/2023

14:31:15

1026

151.4

CHIX

00381274377TRLO0.1.1

06/12/2023

14:31:15

388

151.4

BATE

00381274378TRLO0.1.1

06/12/2023

14:31:15

1539

151.8

XLON

00381274380TRLO0.1.1

06/12/2023

14:31:15

107

151.8

TRQX

00381274379TRLO0.1.1

06/12/2023

14:34:24

335

151

XLON

00381278126TRLO0.1.1

06/12/2023

14:35:04

335

151

XLON

00381278720TRLO0.1.1

06/12/2023

14:35:38

335

151

XLON

00381279171TRLO0.1.1

06/12/2023

14:36:34

335

151

XLON

00381279758TRLO0.1.1

06/12/2023

14:37:13

500

151

XLON

00381280244TRLO0.1.1

06/12/2023

14:38:12

500

151

XLON

00381280932TRLO0.1.1

06/12/2023

14:38:12

500

151.6

XLON

00381280933TRLO0.1.1

06/12/2023

14:38:56

500

151

XLON

00381281425TRLO0.1.1

06/12/2023

14:39:26

500

151

XLON

00381281786TRLO0.1.1

06/12/2023

14:40:26

500

151

XLON

00381282773TRLO0.1.1

06/12/2023

14:43:26

500

151

XLON

00381285224TRLO0.1.1

06/12/2023

14:46:18

500

151

XLON

00381287885TRLO0.1.1

06/12/2023

14:48:25

330

151

XLON

00381290828TRLO0.1.1

06/12/2023

15:09:46

500

151.6

XLON

00381306469TRLO0.1.1

06/12/2023

15:25:33

513

151.2

CHIX

00381318536TRLO0.1.1

06/12/2023

15:25:33

72

151.2

XLON

00381318537TRLO0.1.1

06/12/2023

15:25:33

1467

151.2

XLON

00381318538TRLO0.1.1

06/12/2023

15:25:36

513

151

XLON

00381318596TRLO0.1.1

06/12/2023

15:25:38

89

151

CHIX

00381318632TRLO0.1.1

06/12/2023

15:25:38

526

151

CHIX

00381318633TRLO0.1.1

06/12/2023

15:25:42

149

150.2

AQXE

00381318678TRLO0.1.1

06/12/2023

15:26:34

388

150.2

BATE

00381319447TRLO0.1.1

06/12/2023

15:26:36

2038

150

XLON

00381319471TRLO0.1.1

06/12/2023

15:26:45

513

149

CHIX

00381319558TRLO0.1.1

06/12/2023

15:26:45

1539

149.2

XLON

00381319559TRLO0.1.1

06/12/2023

15:27:12

149

148.6

AQXE

00381319755TRLO0.1.1

06/12/2023

15:27:17

107

148.2

TRQX

00381319820TRLO0.1.1

06/12/2023

15:28:06

28

146.2

BATE

00381320221TRLO0.1.1

06/12/2023

15:28:06

513

146.4

XLON

00381320222TRLO0.1.1

06/12/2023

15:28:28

214

147.2

TRQX

00381320312TRLO0.1.1

06/12/2023

15:31:10

207

147

AQXE

00381321443TRLO0.1.1

06/12/2023

15:31:10

388

147.2

BATE

00381321444TRLO0.1.1

06/12/2023

15:32:18

360

148

BATE

00381322020TRLO0.1.1

06/12/2023

15:34:30

388

148

BATE

00381322928TRLO0.1.1

06/12/2023

15:34:58

513

147.6

XLON

00381323089TRLO0.1.1

06/12/2023

15:35:08

393

146.8

BATE

00381323241TRLO0.1.1

06/12/2023

15:35:08

107

146.8

TRQX

00381323242TRLO0.1.1

06/12/2023

15:35:08

107

146.8

TRQX

00381323243TRLO0.1.1

06/12/2023

16:03:52

1539

150.8

XLON

00381340964TRLO0.1.1

06/12/2023

16:03:52

464

150.6

CHIX

00381340965TRLO0.1.1

06/12/2023

16:03:52

207

150.6

CHIX

00381340966TRLO0.1.1

06/12/2023

16:03:52

91

150.6

CHIX

00381340967TRLO0.1.1

06/12/2023

16:05:18

1539

149.4

XLON

00381341447TRLO0.1.1

06/12/2023

16:05:18

383

149

BATE

00381341448TRLO0.1.1

06/12/2023

16:05:22

107

147.6

TRQX

00381341462TRLO0.1.1

06/12/2023

16:05:22

138

147.6

AQXE

00381341461TRLO0.1.1

06/12/2023

16:07:15

513

146.2

XLON

00381342269TRLO0.1.1

06/12/2023

16:07:15

513

146.2

XLON

00381342270TRLO0.1.1

06/12/2023

16:15:20

2

146.2

BATE

00381347965TRLO0.1.1

06/12/2023

16:15:20

519

146.2

CHIX

00381347964TRLO0.1.1

06/12/2023

16:15:20

513

146.2

XLON

00381347966TRLO0.1.1

06/12/2023

16:15:20

340

146.2

XLON

00381347967TRLO0.1.1

06/12/2023

16:15:20

1

146.2

AQXE

00381347968TRLO0.1.1

06/12/2023

16:17:06

367

145.8

XLON

00381348787TRLO0.1.1

06/12/2023

16:17:06

42

145.8

XLON

00381348786TRLO0.1.1

06/12/2023

16:19:54

51

145.6

CHIX

00381350093TRLO0.1.1

06/12/2023

16:19:54

463

145.6

XLON

00381350094TRLO0.1.1

06/12/2023

16:19:54

327

145.6

XLON

00381350095TRLO0.1.1

06/12/2023

16:19:54

3

145

TRQX

00381350096TRLO0.1.1

06/12/2023

16:26:24

91

145.2

XLON

00381355271TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFFFFIFRLRIIV
Date   Source Headline
10th Jun 20265:38 pmRNSResult of AGM
9th Jun 20267:00 amRNS-RPRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.